Ajinomoto Bio-Pharma Services India Private Limited, a active private limited company, was established on 02 September 2011 in Anakapalle, Andhra Pradesh, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24233AP2011PTC117217. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹95.00 Cr and a paid-up capital of ₹85.76 Cr.
Formerly known as Granules Omnichem Private Limited. It upholds a compliant status. Employing 159 professional, Its leadership includes Patrick Juliaan E De Craene (Director), Venkata Viswanadha Raju Kakarlapudi (Managing Director), Els Roeland (Director). Past directors included Venkata Satyanarayana Murthy Vadali, Jean Baptiste Xavier Agnus, Chigurupati Krishna Prasad. It holds no open charges and ₹185.20 Cr settled loans. Its latest AGM occurred on 12 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.121 (Part) &122, Visakha Pharma City Limited, Sez, Parawada, Lankelapalem, Anakapalle, Andhra Pradesh, 531019.
U24233AP2011PTC117217
117217
02 September 2011
₹95.00 Cr
₹85.76 Cr
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Ajinomoto Bio-Pharma Services India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Patrick Juliaan E De Craene | Director | 10 Jun 2021 | Current |
| Venkata Viswanadha Raju Kakarlapudi | Managing Director | 29 May 2020 | Current |
| Els Roeland | Director | 14 Apr 2023 | Current |
| Kristof Laura H Van Belleghem | Director | 22 May 2025 | Current |
| Wouter Maria F Biesmans | Director | 22 May 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Sep 2017 | Past |
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Nominee Director | 29 May 2020 | Past |
| Pramod Abcsdd | Nominee Director | 29 May 2020 | Past |
| Pramod Abcsdd | Nominee Director | 11 May 2015 | Past |
| Pramod Abcsdd | Key Managerial Personnel | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Ajinomoto Bio-Pharma Services India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹1,852,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Oct 2016 | Others | ₹61.00 Cr | Satisfied |
| 23 Apr 2013 | Ing Bank Nv Singapore Branch | ₹62.10 Cr | Satisfied |
| 23 Apr 2013 | Deg - Deutsche Investitions - Und Entwicklungsgesellschaft Mbh | ₹62.10 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Ajinomoto Bio-Pharma Services India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ajinomoto Bio-Pharma Services India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ajinomoto Bio-Pharma Services India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ajinomoto Bio-Pharma Services India Private Limited last Annual general meeting of members was held on 12 Sep 2025 as per latest MCA records. was recorded as a recent event.
Progress on Kristof Laura H Van Belleghem was appointed as a Director was appointed as a Director on 22 May 2025 & has been associated with this company since 6 months 8 days . was documented.
The activity Wouter Maria F Biesmans was appointed as a Director was appointed as a Director on 22 May 2025 & has been associated with this company since 6 months 8 days . was completed.
Ajinomoto Bio-Pharma Services India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada. was recorded as a recent event.
Progress on Els Roeland was appointed as a Director was appointed as a Director on 14 Apr 2023 & has been associated with this company since 2 years 7 months . was documented.
Srivenkata Subrahmanya Sarma Kuchi was appointed as a Cfo was appointed as a Cfo on 28 Jun 2022 & has been associated with this company since 3 years 5 months . was recorded as a recent event.
The transaction will reach completion during the fourth quarter of 2019. .
The CIN of Ajinomoto Bio-Pharma Services India Private Limited is U24233AP2011PTC117217.
Ajinomoto Bio-Pharma Services India Private Limited is headquartered at Plot No.121 (Part) &122, Visakha Pharma City Limited, Sez, Parawada, Lankelapalem, Anakapalle, Andhra Pradesh, 531019.
Ajinomoto Bio-Pharma Services India Private Limited was incorporated on 02 September 2011.
The current directors of Ajinomoto Bio-Pharma Services India Private Limited are
The primary industry of Ajinomoto Bio-Pharma Services India Private Limited is Manufacturing.
Ajinomoto Bio-Pharma Services India Private Limited is unlisted.
The authorized capital of Ajinomoto Bio-Pharma Services India Private Limited is ₹95.00 Cr, and the paid-up capital is ₹85.76 Cr.
The compliance status of Ajinomoto Bio-Pharma Services India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX